Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-24-019716
Filing Date
2024-11-27
Accepted
2024-11-26 18:51:51
Documents
4
Period of Report
2024-11-26

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k.htm 6-K 4087
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 16509
3 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 10354
4 GRAPHIC exhibit99-2x001.jpg GRAPHIC 3848
  Complete submission text file 0001062993-24-019716.txt   37706
Mailing Address SUITE 1900-855 WEST GEORGIA STREET VANCOUVER A1 V6C 3H4
Business Address SUITE 1900-855 WEST GEORGIA STREET VANCOUVER A1 V6C 3H4 604-336-8613
C21 Investments Inc. (Filer) CIK: 0000831609 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 000-55982 | Film No.: 241505875
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)